Thrivent Financial for Lutherans’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$155M Buy
582,313
+128,636
+28% +$35.6M 0.3% 64
2025
Q4
$125M Buy
453,677
+162,023
+56% +$45.4M 0.22% 90
2025
Q3
$84.1M Buy
291,654
+22,721
+8% +$6.72M 0.17% 144
2025
Q2
$88.9M Buy
268,933
+2,077
+0.8% +$670K 0.19% 131
2025
Q1
$87.8M Sell
266,856
-3,149
-1% -$949K 0.19% 130
2024
Q4
$74.6M Sell
270,005
-6,014
-2% -$1.92M 0.14% 190
2024
Q3
$95.6M Sell
276,019
-2,092
-0.8% -$720K 0.18% 140
2024
Q2
$91.9M Buy
278,111
+1,017
+0.4% +$351K 0.19% 140
2024
Q1
$101M Buy
277,094
+36,137
+15% +$11.9M 0.2% 128
2023
Q4
$72.2M Sell
240,957
-107,057
-31% -$31.3M 0.16% 184
2023
Q3
$99.6M Sell
348,014
-10,043
-3% -$2.86M 0.24% 111
2023
Q2
$100M Sell
358,057
-10,056
-3% -$2.62M 0.23% 120
2023
Q1
$94.1M Sell
368,113
-78,102
-18% -$22.8M 0.23% 120
2022
Q4
$148M Sell
446,215
-18,880
-4% -$5.97M 0.38% 48
2022
Q3
$129M Sell
465,095
-83,456
-15% -$23.5M 0.35% 56
2022
Q2
$145M Buy
548,551
+157,800
+40% +$40.7M 0.39% 44
2022
Q1
$93.6M Buy
390,751
+14,319
+4% +$3.35M 0.18% 140
2021
Q4
$86.5M Buy
376,432
+9,089
+2% +$1.93M 0.17% 155
2021
Q3
$73.6M Sell
367,343
-14,991
-4% -$3.26M 0.15% 175
2021
Q2
$90.6M Sell
382,334
-8,508
-2% -$2.13M 0.18% 139
2021
Q1
$94.5M Buy
390,842
+17,601
+5% +$3.92M 0.21% 115
2020
Q4
$77.7M Sell
373,241
-19,520
-5% -$3.83M 0.18% 138
2020
Q3
$66.5M Sell
392,761
-27,157
-6% -$4.78M 0.18% 138
2020
Q2
$78.8M Buy
419,918
+118,930
+40% +$22.6M 0.24% 97
2020
Q1
$53.3M Sell
300,988
-6,836
-2% -$1.33M 0.19% 128
2019
Q4
$62.9M Buy
307,824
+147,594
+92% +$27.1M 0.18% 150
2019
Q3
$24.3M Buy
160,230
+894
+0.6% +$145K 0.08% 281
2019
Q2
$25.1M Sell
159,336
-140,953
-47% -$22.1M 0.08% 290
2019
Q1
$48.3M Buy
300,289
+140,979
+88% +$25.7M 0.15% 179
2018
Q4
$30.3M Buy
159,310
+148,376
+1,357% +$31M 0.11% 205
2018
Q3
$2.28M Sell
10,934
-61,628
-85% -$11.4M 0.01% 846
2018
Q2
$12.3M Buy
72,562
+40,678
+128% +$7.04M 0.04% 437
2018
Q1
$5.35M Sell
31,884
-434,698
-93% -$84.5M 0.02% 634
2017
Q4
$94.8M Buy
466,582
+4,685
+1% +$932K 0.32% 69
2017
Q3
$86.3M Sell
461,897
-1,713
-0.4% -$305K 0.31% 79
2017
Q2
$77.6M Sell
463,610
-244,780
-35% -$39.3M 0.32% 73
2017
Q1
$104M Buy
708,390
+699,500
+7,868% +$103M 0.45% 53
2016
Q4
$1.19M Buy
8,890
+500
+6% +$65.4K 0.01% 1061
2016
Q3
$1.09M Buy
8,390
+360
+4% +$47K 0.01% 1100
2016
Q2
$1.03M Buy
8,030
+550
+7% +$72.6K ﹤0.01% 1088
2016
Q1
$1.03M Buy
7,480
+270
+4% +$37.1K 0.01% 1068
2015
Q4
$1.05M Buy
7,210
+210
+3% +$28.9K 0.01% 1046
2015
Q3
$945K Buy
7,000
+350
+5% +$50.8K 0.01% 980
2015
Q2
$1.08M Buy
6,650
+400
+6% +$55.3K 0.01% 803
2015
Q1
$809K Hold
6,250
﹤0.01% 909
2014
Q4
$643K Hold
6,250
﹤0.01% 992
2014
Q3
$567K Sell
6,250
-150
-2% -$14K ﹤0.01% 1051
2014
Q2
$589K Sell
6,400
-50
-0.8% -$4.29K ﹤0.01% 1052
2014
Q1
$540K Sell
6,450
-114,379
-95% -$9.42M ﹤0.01% 925
2013
Q4
$10.6M Sell
120,829
-100
-0.1% -$8.18K 0.06% 298
2013
Q3
$9.29M Buy
120,929
+500
+0.4% +$39K 0.06% 324
2013
Q2
$8.73K Buy
+120,429
New +$8.12M 0.06% 330

Other funds holding CI

Thrivent Financial for Lutherans's CI Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Cigna (CI) stake by 28% in Q1 2026, buying an estimated $35.6M and bringing the position to 582,313 shares worth $155M. The position accounts for 0.3% of the portfolio, ranked #64.

Thrivent Financial for Lutherans first reported a position in CI in Q2 2013 and has held it in 52 quarters since. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Thrivent Financial for Lutherans held 582,313 shares of Cigna worth $155M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 128,636 Cigna shares in Q1 2026, an estimated $35.6M.
  • Cigna made up 0.3% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #64 holding.
  • Thrivent Financial for Lutherans first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.